Bone Marrow TransplantationTransplantation, AutologousTransplantation, HomologousBone MarrowBone Marrow CellsBone Marrow PurgingGraft vs Host DiseaseWhole-Body IrradiationHematopoietic Stem Cell TransplantationTransplantation ConditioningCombined Modality TherapyCyclophosphamideLymphoma, Non-HodgkinCarmustineBusulfanLiver TransplantationLeukemiaGraft SurvivalTransplantation ChimeraRemission InductionMelphalanRecurrenceBone and BonesTissue DonorsLeukemia, Myeloid, AcuteHematopoietic Stem CellsAntineoplastic Combined Chemotherapy ProtocolsAnemia, AplasticTreatment OutcomeTransplantation, IsogeneicHodgkin DiseaseEtoposideKidney TransplantationStem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibility TestingLeukemia, MyeloidHistocompatibilityBone Marrow DiseasesCytarabineHematopoiesisSurvival AnalysisHematologic NeoplasmsColony-Forming Units AssayTime FactorsActuarial AnalysisAcute DiseaseImmunosuppressive AgentsGraft RejectionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation ImmunologyImmunosuppressionSurvival RateDisease-Free SurvivalLymphomaSalvage TherapyRetrospective StudiesHeart TransplantationHepatic Veno-Occlusive DiseaseGranulocyte Colony-Stimulating FactorMyelodysplastic SyndromesMice, Inbred C57BLFollow-Up StudiesMultiple MyelomaT-LymphocytesVincristineCyclosporinePodophyllotoxinGraft vs Tumor EffectLymphocyte DepletionRadiation ChimeraLung TransplantationDrug EvaluationLeukocyte CountBone Marrow ExaminationGraft vs Host ReactionHLA AntigensPrognosisThiotepaHematologic DiseasesGraft vs Leukemia EffectPeripheral Blood Stem Cell TransplantationLymphocyte TransfusionLeukocyte TransfusionOrgan TransplantationBone RemodelingHematopoietic Stem Cell MobilizationAntibodies, MonoclonalBone Marrow NeoplasmsAntigens, CD34Nuclear FamilyProspective StudiesNeoplasm, ResidualLife TablesChimeraPrednisoneSevere Combined ImmunodeficiencyCell SeparationGranulocytesPlatelet Count